108 related articles for article (PubMed ID: 235609)
1. A crystallographic and theoretical study of the conformation of DOET and its significance for the hallucinogenic amphetamines.
Horn AS; Post ML; Kennard O; Di Sanserverino R
J Pharm Pharmacol; 1975 Jan; 27(1):13-7. PubMed ID: 235609
[TBL] [Abstract][Full Text] [Related]
2. The effects of 2,5-dimethoxy-4-methylamphetamine (DOM), 2,5-dimethoxy-4-ethylamphetamine (DOET), d-amphetamine, and cocaine in rats trained with mescaline as a discriminative stimulus.
Winter JC
Psychopharmacologia; 1975 Oct; 44(1):29-32. PubMed ID: 1197576
[TBL] [Abstract][Full Text] [Related]
3. [Studies on the identification of psychotropic substances. VI. Preparation and various analytical data of reference standards of some hallucinogens, 2,5-dimethoxy-4-methylamphetamine (STP), 2,5-dimethoxy-4-bromoamphetamine (DOB) and 2,5-dimethoxy-4-ethylamphetamine (DOET)].
Shimamine M; Takahashi K; Nakahara Y
Eisei Shikenjo Hokoku; 1989; (107):113-9. PubMed ID: 2636911
[TBL] [Abstract][Full Text] [Related]
4. Radioimmunoassays of 3,4,5-trimethoxyphenethylamine (mescaline) and 2,5-dimethoxy-4-methylphenyl-isopropylamine(DOM).
Riceberg LJ; Van Vunakis H; Levine L
Anal Biochem; 1974 Aug; 60(2):551-9. PubMed ID: 4210779
[No Abstract] [Full Text] [Related]
5. Dissociations between the effects of hallucinogenic drugs on behavior and raphe unit activity in freely moving cats.
Trulson ME; Heym J; Jacobs BL
Brain Res; 1981 Jun; 215(1-2):275-93. PubMed ID: 6114779
[TBL] [Abstract][Full Text] [Related]
6. Scratching response induced in mice by mescaline and related amphetamine derivatives.
Kulkarni AS
Biol Psychiatry; 1973 Apr; 6(2):177-80. PubMed ID: 4709133
[No Abstract] [Full Text] [Related]
7. Steric and electronic relationships among some hallucinogenic compounds.
Kang S; Green JP
Proc Natl Acad Sci U S A; 1970 Sep; 67(1):62-7. PubMed ID: 5272329
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the behavioral effects of mescaline analogs using the head twitch response in mice.
Halberstadt AL; Chatha M; Chapman SJ; Brandt SD
J Psychopharmacol; 2019 Mar; 33(3):406-414. PubMed ID: 30789291
[TBL] [Abstract][Full Text] [Related]
9. Differences in the stimulus properties of 3,4-methylenedioxyamphetamine and 3,4- methylenedioxymethamphetamine in animals trained to discriminate hallucinogens from saline.
Callahan PM; Appel JB
J Pharmacol Exp Ther; 1988 Sep; 246(3):866-70. PubMed ID: 2901488
[TBL] [Abstract][Full Text] [Related]
10. Direct comparison of hallucinogenic phenethylamines and D-amphetamine on dorsal raphe neurons.
Penington NJ; Reiffenstein RJ
Eur J Pharmacol; 1986 Apr; 122(3):373-7. PubMed ID: 3709659
[TBL] [Abstract][Full Text] [Related]
11. 2,5-dimethoxy-4-methyl-amphetamine (STP): a new hallucinogenic drug.
Snyder SH; Faillace L; Hollister L
Science; 1967 Nov; 158(3801):669-70. PubMed ID: 4860952
[TBL] [Abstract][Full Text] [Related]
12. Molecular structures of hallucinogenic substances: lysergic acid diethylamide, psilocybin, and 2,4,5-trimethoxyamphetamine.
Baker RW; Chothia C; Pauling P; Weber HP
Mol Pharmacol; 1973 Jan; 9(1):23-32. PubMed ID: 4685449
[No Abstract] [Full Text] [Related]
13. Effects of psychotomimetics on vascular strips: studies of methoxylated amphetamines and optical isomers of 2,5-dimethoxy-4-methylamphetamine and 2,5-dimethoxy-4-bromoamphetamine.
Cheng HC; Long JP; Nichols DE; Barfknecht CF
J Pharmacol Exp Ther; 1974 Jan; 188(1):114-23. PubMed ID: 4809263
[No Abstract] [Full Text] [Related]
14. Molecular connectivity analysis of hallucinogenic mescaline analogs.
Glennon RA; Kier LB; Shulgin AT
J Pharm Sci; 1979 Jul; 68(7):906-7. PubMed ID: 458614
[TBL] [Abstract][Full Text] [Related]
15. Assessment of tolerance to the hallucinogenic effects of DOM.
Angrist B; Rotrosen J; Gershon S
Psychopharmacologia; 1974 Apr; 36(3):203-7. PubMed ID: 4844244
[No Abstract] [Full Text] [Related]
16. Cardiovascular and gross behavioral effects of amphetamine, 2-amino-1-(2,5-dimethoxy-4-methylphenyl) propane (DOM) and 2-amino-1-(2,5-dimethoxy-4-methylphenyl) butane (BL-3912A) in the conscious dog.
Buyniski JP; Smith ML; Bierwagen ME
Res Commun Chem Pathol Pharmacol; 1974 Jun; 8(2):213-21. PubMed ID: 4859236
[No Abstract] [Full Text] [Related]
17. PATTERNS OF HALLUCINOGENIC DRUG ABUSE.
LUDWIG AM; LEVINE J
JAMA; 1965 Jan; 191():92-6. PubMed ID: 14233246
[No Abstract] [Full Text] [Related]
18. Identification of the N-methylated analogs of the hallucinogenic amphetamines and some isomers.
Bailey K; By AW; Legault D; Verner D
J Assoc Off Anal Chem; 1975 Jan; 58(1):62-9. PubMed ID: 1141157
[TBL] [Abstract][Full Text] [Related]
19. Neurological aspects of hallucinogenic drugs.
Logan WJ
Adv Neurol; 1975; 13():47-78. PubMed ID: 814800
[No Abstract] [Full Text] [Related]
20. Crystallographic, theoretical and molecular modelling studies on the conformations of the salicylamide, raclopride, a selective dopamine-D2 antagonist.
Högberg T; Norinder U; Rämsby S; Stensland B
J Pharm Pharmacol; 1987 Oct; 39(10):787-96. PubMed ID: 2891816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
